The first selected projects to be incubated in the I2D2 initiative are:
Selected Programs
| Code | Title | Therapeutic area | Proposer institution | Proposer researcher |
|---|---|---|---|---|
| FK087 | Development of new HDAC6 inhibitor for autoinmune and neurodegenerative diseases | Neurosciencies | Quimatryx SL | Yosu Ion Vara Salazar |
| FK079 | Allosteric modulators of the dopamine D1 receptor | Neurosciencies | Universidad Complutense de Madrid | María Luz López Rodríguez |
| FK080 | Inhibition of p38γ as a treatment for steatosis and liver cancer | Oncology | Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) | Guadalupe Sabio |
